Use of glucose uptake enhancer for reducing post-ischemic injury of the heart

Details for Australian Patent Application No. 2005202209 (hide)

Owner SmithKline Beecham p.l.c. SmithKline Beecham Laboratoires Pharmaceutiques

Inventors Khandoudi, Nassirah; Bril, Antoine Michel Alain; Buckingham, Robin Edwin

Agent Davies Collison Cave

Pub. Number AU-A-2005202209

Parent 27683

Filing date 20 May 2005

Wipo publication date 16 June 2005

International Classifications

A61K 031/00

A61K 031/425 - Thiazoles

A61K 031/44 - Non-condensed pyridines

Event Publications

2 June 2005 Complete Application Filed

16 June 2005 Application Open to Public Inspection

  Published as AU-A-2005202209

1 March 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005202210-Method for operating a wind energy plant

2005202208-Method and apparatus for credential management on a portable device